Your browser doesn't support javascript.
loading
Does the Timing of Eribulin Treatment for Advanced or Metastatic Breast Cancer Matter? Evidence from a Real-World Setting.
Chen, Chih-Jung; Nguyen, Hanh T H; Huang, Chih-Hao; Wang, Hwei-Chung; Wu, Chen-Teng; Wu, Yao-Chung; He, Geng-Yan; Chou, Chiahung; Lin, Hsiang-Wen; Liu, Liang-Chih.
Afiliação
  • Chen CJ; Surgical Department, China Medical University Hospital, Taichung, Taiwan.
  • Nguyen HTH; School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan.
  • Huang CH; Department of Clinical Pharmacy, Hanoi University of Pharmacy, Hanoi, Vietnam.
  • Wang HC; Surgical Department, China Medical University Hospital, Taichung, Taiwan.
  • Wu CT; Surgical Department, China Medical University Hospital, Taichung, Taiwan.
  • Wu YC; Surgical Department, China Medical University Hospital, Taichung, Taiwan.
  • He GY; Surgical Department, China Medical University Hospital, Taichung, Taiwan.
  • Chou C; Surgical Department, China Medical University Hospital, Taichung, Taiwan.
  • Lin HW; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, Alabama, USA.
  • Liu LC; School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan.
Chemotherapy ; 68(1): 23-34, 2023.
Article em En | MEDLINE | ID: mdl-36108618
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neutropenia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neutropenia Idioma: En Ano de publicação: 2023 Tipo de documento: Article